日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Characteristics of children with severe preschool asthma prior to starting the TIPP study

TIPP 研究开始前患有严重学龄前哮喘的儿童的特征

期刊:Frontiers in Pediatrics
影响因子:2
doi:10.3389/fped.2025.1558256
Zielen, S; Wosniok, J; Wollscheid, N; Nickolay, T; Grimmel, C; Scheele, D; Sattler, F; Prenzel, F; Lorenz, M; Schaub, B; Lex, C; Dahlheim, M; Trischler, J; Donath, H; Lau, S; Hamelmann, E; Vogelberg, C; Gerstlauer, M; Wetzke, M; Schubert, R; Schollenberger, L; Gappa, M
哮喘
发表日期：2025
文献求助 收藏

Liver Assessment in Patients with Ataxia-Telangiectasia: Transient Elastography Detects Early Stages of Steatosis and Fibrosis

共济失调毛细血管扩张症患者的肝脏评估：瞬时弹性成像可检测早期脂肪变性和纤维化

期刊:Canadian Journal of Gastroenterology and Hepatology
影响因子:2.3
doi:10.1155/2023/2877350
Donath, H; Wölke, S; Knop, V; Heß, U; Duecker, R P; Trischler, J; Poynard, T; Schubert, R; Zielen, S
发表日期：2023
文献求助 收藏

Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia

神经丝轻链是毛细血管扩张性共济失调症神经退行性变的生物标志物

期刊:Cerebellum
影响因子:2.4
doi:10.1007/s12311-021-01257-4
Donath, H; Woelke, S; Schubert, R; Kieslich, M; Theis, M; Auburger, G; Duecker, R P; Zielen, S
神经科学
发表日期：2022
文献求助 收藏

Correction to: Neurofilament Light Chain is a Biomarker of Neurodegeneration in Ataxia Telangiectasia

更正：神经丝轻链是毛细血管扩张性共济失调症神经退行性变的生物标志物

期刊:Cerebellum
影响因子:2.4
doi:10.1007/s12311-021-01280-5
Donath, H; Woelke, S; Schubert, R; Kieslich, M; Theis, M; Auburger, G; Duecker, R P; Zielen, S
神经科学
发表日期：2022
文献求助 收藏

Altered Cerebrospinal Fluid (CSF) in Children with Ataxia Telangiectasia

共济失调毛细血管扩张症患儿的脑脊液改变

期刊:Cerebellum
影响因子:2.4
doi:10.1007/s12311-020-01175-x
Woelke, S; Schrewe, R; Donath, H; Theis, M; Kieslich, M; Duecker, R; Auburger, G; Schubert, R; Zielen, S
神经科学
发表日期：2021
文献求助 收藏

Oil supplementation with a special combination of n-3 and n-6 long-chain polyunsaturated fatty acids does not protect for exercise induced asthma: a double-blind placebo-controlled trial

一项双盲安慰剂对照试验表明，补充含有特殊组合的n-3和n-6长链多不饱和脂肪酸的油脂并不能预防运动诱发性哮喘。

期刊:Lipids in Health and Disease
影响因子:4.2
doi:10.1186/s12944-020-01343-2
Dreßler, M; Fussbroich, D; Böhler, L; Herrmann, E; Benker, N; Tytyk, M; Schulze, J; Schubert, R; Beermann, C; Zielen, S
哮喘
代谢
发表日期：2020
文献求助 收藏

Calprotectin as a New Sensitive Marker of Neutrophilic Inflammation in Patients with Bronchiolitis Obliterans

钙卫蛋白作为闭塞性细支气管炎患者中性粒细胞炎症的新型敏感标志物

期刊:Mediators of Inflammation
影响因子:4.2
doi:10.1155/2020/4641585
Jerkic, S P; Michel, F; Donath, H; Herrmann, E; Schubert, R; Rosewich, M; Zielen, S
炎症
中性粒细胞
炎症/感染
Immunology/Inflammation
粒细胞
支气管炎
细胞生物学
发表日期：2020
文献求助 收藏

Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing

使用结膜激发试验发现，PQ草免疫疗法后剂量反应显著。

期刊:World Allergy Organization Journal
影响因子:4.3
doi:10.1016/j.waojou.2019.100075
Zielen, S; Kuna, P; Aberer, W; Lassmann, S; Pfaar, O; Klimek, L; Wade, A; Kluehr, K; Raab, J; Wessiepe, D; Lee, D; Kramer, M F; Gunawardena, K; Higenbottam, T; Heath, M D; Skinner, M A; de Kam, P J
免疫/内分泌
发表日期：2019
文献求助 收藏

Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real-world database analysis

舌下免疫疗法可长期缓解过敏性鼻炎症状并降低哮喘风险：一项回顾性真实世界数据库分析

期刊:Allergy
影响因子:12
doi:10.1111/all.13213
Zielen, S; Devillier, P; Heinrich, J; Richter, H; Wahn, U
哮喘
炎症
炎症/感染
鼻炎
免疫/内分泌
发表日期：2018
文献求助 收藏

Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy

随机对照试验确定了Pollinex Quattro桦树过敏原免疫疗法的剂量反应曲线。

期刊:Allergy
影响因子:12
doi:10.1111/all.13478
Worm, M; Higenbottam, T; Pfaar, O; Mösges, R; Aberer, W; Gunawardena, K; Wessiepe, D; Lee, D; Kramer, M F; Skinner, M; Lees, B; Zielen, S
免疫/内分泌
发表日期：2018
文献求助 收藏